Clara Biotech hits $850K in seed funding roundup, preparing to launch first product
June 15, 2021 | Startland News Staff
An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs.
“We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said Jim West, co-founder of Clara Biotech, a Lawrence-based company already buoyed by its founding team’s expertise in exosome technologies, pharmaceutical development, engineering and building life science companies.
Elevator pitch: Clara Biotech is building an exosome isolation platform that solves a huge roadblock around manufacturing that helps the entire biopharma industry make future breakthrough drugs that may not otherwise get approved. We founded Clara Biotech to help move exosomes from research to patient.
Jim West, Clara Biotech
“We’re looking for smart money investors who can help us develop our market position, scale the technology and become the platform that companies can use to get exosome therapies to the patients who need them most,” he continued, detailing Clara Biotech’s momentum in a company snapshot update.
Off the heels of announcing an undisclosed investment by Kansas City-based Fountain Innovation Fund, the startup has raised $850,000 for its seed round, West said, with additional investments from angel investors in Boston, San Francisco, India and Kansas City.
Dr. Mei He, Clara Biotech
Clara Biotech recently received a tranche of angel tax credits, still available to qualified investors, he added.
The seed round is expected to help the company debut its beta ExoRelease exosome isolation kit, as well as continue to scale, West said.
Click here to read Clara Biotech’s full snapshot update.
“We are generating revenue and launching our first product,” he said. “At a recent conference for exosome therapeutics, sample preparation quality was the major limiting factor in manufacturing and receiving FDA approval. Our groundbreaking solution resulted in a 70 percent lead conversion rate of all companies attending (which includes investment groups and competitors). We’re currently working with and growing a number of paying early customers including some major pharmaceutical players.”
Founded in 2018 at the Bioscience and Technology Business Center in Lawrence, Clara Biotech’s therapeutic applications range from personalized medicine, targeted drug delivery, immunotherapy, and orphan and rare diseases. It’s solutions are focused on early cancer detection, Alzheimer’s disease, and virus detection.
Click here to learn more about Clara Biotech and how its technology works.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that seeks to build inclusive prosperity through a prepared workforce and entrepreneur-focused economic development. The Foundation works to change conditions, address root causes, and break down systemic barriers so that all people – regardless of race, gender, or geography – have the opportunity to achieve economic stability, mobility, and prosperity.
For more information, visit www.kauffman.org and connect with us at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.
2021 Startups to Watch
stats here
Related Posts on Startland News
Blackhole Bakery plans bodega-style expansion for second location: a West Plaza ‘blank canvas’
During his five years operating on Troost, Jason Provo said real estate agents often approached him, asking, “When are you going to leave and get a big boy spot in Leawood?” Now the owner of beloved Blackhole Bakery is planning his second location. But not in Johnson County. Provo is taking over a space at…
Dublin down on shenanigans: Smoke Brewing goes green with St. Patrick’s season pop-up
St. Patrick’s Day-themed Shenanigans is now open in downtown Lee’s Summit. But just until March 23. The owners of Smoke Brewing Company at 209 S.E. Main St. decked out the barbecue restaurant and brewery in floor-to-ceiling St. Paddy’s decor, and have food and drink specials to match. It’s a way to make St. Patrick’s Day…
The game is rigged; the goalposts move (and we still have to pretend it’s fair)
Editor’s note: The perspectives expressed in this commentary are the author’s alone. JQ Sirls is an author and illustrator, as well as co-founder and CEO of Storytailor — an AI-infused storytelling platform that turns children’s emotions and challenges into adventures filled with imagination and wonder. His company was named one of Startland News’ Kansas City…
How Trump’s win on DEI means fewer fresh foods for KC’s east side; USDA rakes back critical grant for farmers market
An ambitious plan to create greater food security through urban farming won’t be entirely uprooted by efforts to dry up federal funding for projects linked to equity and access, said Alana Henry — but its harvest likely will yield dramatically less. “Doing right by people is always the right answer,” said Henry, executive director of…